BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1254 related articles for article (PubMed ID: 30100199)

  • 1. Exploring pharmacy service users' support for and willingness to use community pharmacist prescribing services.
    Famiyeh IM; MacKeigan L; Thompson A; Kuluski K; McCarthy LM
    Res Social Adm Pharm; 2019 May; 15(5):575-583. PubMed ID: 30100199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial perceptions of key stakeholders in Ontario regarding independent prescriptive authority for pharmacists.
    Pojskic N; MacKeigan L; Boon H; Austin Z
    Res Social Adm Pharm; 2014; 10(2):341-54. PubMed ID: 23816494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates.
    Alzubaidi H; Saidawi W; Mc Namara K
    Int J Clin Pharm; 2018 Oct; 40(5):1106-1115. PubMed ID: 29926256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist Intentions to Prescribe Hormonal Contraception Following New Legislative Authority in California.
    Vu K; Rafie S; Grindlay K; Gutierrez H; Grossman D
    J Pharm Pract; 2019 Feb; 32(1):54-61. PubMed ID: 29096570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist prescribing: A scoping review about the views and experiences of patients and the public.
    Famiyeh IM; McCarthy L
    Res Social Adm Pharm; 2017; 13(1):1-16. PubMed ID: 26898951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
    Wibowo Y; Sunderland B; Hughes J
    Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist prescribing: a cross-sectional survey of the views of pharmacists in Nigeria.
    Auta A; Strickland-Hodge B; Maz J; David S
    Int J Pharm Pract; 2018 Apr; 26(2):111-119. PubMed ID: 28497878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stakeholders' views on granting prescribing authority to pharmacists in Nigeria: a qualitative study.
    Auta A; Strickland-Hodge B; Maz J
    Int J Clin Pharm; 2016 Aug; 38(4):960-7. PubMed ID: 27194098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
    Gordon C; Unni E; Montuoro J; Ogborn DB
    Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded prescribing: a comparison of the views of Australian hospital and community pharmacists.
    Hoti K; Hughes J; Sunderland B
    Int J Clin Pharm; 2013 Jun; 35(3):469-75. PubMed ID: 23549776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy.
    Latif A; Waring J; Watmough D; Barber N; Chuter A; Davies J; Salema NE; Boyd MJ; Elliott RA
    Res Social Adm Pharm; 2016; 12(6):966-989. PubMed ID: 26806858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family physicians' perceptions of pharmacists prescribing in Alberta.
    Faruquee CF; Khera AS; Guirguis LM
    J Interprof Care; 2020; 34(1):87-96. PubMed ID: 31043099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative interviews regarding pharmacist prescribing in the community setting.
    Feehan M; Durante R; Ruble J; Munger MA
    Am J Health Syst Pharm; 2016 Sep; 73(18):1456-61. PubMed ID: 27605325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mixed methods analysis of community pharmacists' perspectives on delivering COPD screening service to guide future implementation.
    Fathima M; Saini B; Foster JM; Armour CL
    Res Social Adm Pharm; 2019 Jun; 15(6):662-672. PubMed ID: 30131254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacists' views on Indigenous health: is there more that can be done?
    Stoneman J; Taylor SJ
    Rural Remote Health; 2007; 7(3):743. PubMed ID: 17688377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist's Demand for Optimal Primary Care Service Delivery in a Community Pharmacy: The OPTiPharm Study.
    Munger MA; Walsh M; Godin J; Feehan M
    Ann Pharmacother; 2017 Dec; 51(12):1069-1076. PubMed ID: 28737045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hypertension in an Australian community pharmacy setting - patients' beliefs and perspectives.
    Bajorek BV; LeMay KS; Magin PJ; Roberts C; Krass I; Armour CL
    Int J Pharm Pract; 2017 Aug; 25(4):263-273. PubMed ID: 27633151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rural patient perceptions of pharmacist-provided chronic condition management in a state with provider status.
    Frazier KR; McKeirnan KC; Kherghehpoush S; Woodard LJ
    J Am Pharm Assoc (2003); 2019; 59(2):210-216. PubMed ID: 30578126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicians' perspectives of pharmacist-physician collaboration in the United Arab Emirates: Findings from an exploratory study.
    Hasan S; Stewart K; Chapman CB; Kong DCM
    J Interprof Care; 2018 Sep; 32(5):566-574. PubMed ID: 29589781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General practitioners' views of pharmacists' current and potential contributions to medication review and prescribing in New Zealand.
    Hatah E; Braund R; Duffull SB; Tordoff J
    J Prim Health Care; 2013 Sep; 5(3):223-33. PubMed ID: 23998173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.